Market News & Trends
BioAlliance Pharma, TopoTarget A/S to Merge
BioAlliance Pharma SA and Topotarget A/S recently announced the signature of a definitive merger plan to create the combination of BioAlliance Pharma SA and Topotarget…
Viking Signs Broad Licensing Deal With Ligand
Viking Therapeutics, Inc. recently announced it has obtained an exclusive worldwide license to five novel therapeutic programs from Ligand Pharmaceuticals Incorporated. The license includes programs…
GlycoMimetics Receives $15-Million Payment From Pfizer
GlycoMimetics, Inc. recently announced that Pfizer has made a $15-million payment to GlycoMimetics under the terms of the parties’ collaboration for the development of rivipansel…
Adamas Pharmaceuticals Receives $25-Million Milestone Payment From Forest Laboratories
Adamas Pharmaceuticals, Inc. recently announced it has received a $25-million milestone payment from Forest Laboratories Holdings Limited related to the development of MDX-8704. MDX-8704, a…
Personalized Medicine Drives Uptake of Next-Generation Sequencing in Europe, Finds Frost & Sullivan
The Western European next-generation sequencing (NGS) market is poised for steady growth, owing to the emergence of new applications, such as non-invasive prenatal testing and…
Third Rock Ventures & The Column Group Launch Nurix
Third Rock Ventures and The Column Group recently announced the launch of Nurix, Inc., a leader in discovering and developing therapies that modulate the ubiquitin…
PolyTherics & Antitope Form Abzena
PolyTherics Limited recently announced the formation of a new company, Abzena Limited. The new company has been created to provide a strong group identity across…
Eurofins Signs Agreement to Acquire ViraCor-IBT Laboratories
Eurofins Scientific, a global leader in bioanalytical testing and one of the world leaders in genomic services, has signed a definitive agreement to acquire ViraCor-IBT…
Ligand Signs $4.5-Million Agreement With Omthera Pharmaceuticals
Ligand Pharmaceuticals Incorporated recently announced it has entered into a licensing agreement and research collaboration with Omthera Pharmaceuticals, Inc., a wholly owned subsidiary of AstraZeneca…
EMD Millipore Expands Provantage Upstream Bioproduction Services to North American Market
EMD Millipore recently announced the expansion of its upstream services into North America as part of its Provantage Biodevelopment and Clinical Supply offering. The company’s…
Horizon Discovery to Acquire CombinatoRx Service Business & Assets from Zalicus
Horizon Discovery Group plc recently announced it has agreed to acquire the CombinatoRx service business (known as the combination high throughput screening (cHTS) business) and…
cGMP HEPES, MOPS & MES Available With Full Traceability & Secure Supply Chain
BioSpectra recently announced its cGMP, US-manufactured Zwitterionic Buffers are produced in its new FDA-registered facility in Bangor, PA. These buffers include HEPES, MOPS, and MES,…
Volume Rises, Value Falls for M&A Deals in Global Pharmaceutical & Biotechnology Industry
The challenges posed by expiring patents, the global economic slowdown, and price premium pressures are forcing the pharmaceutical and biotech industry to restructure and streamline…
Volume Rises, Value Falls for M&A Deals in Global Pharmaceutical & Biotechnology Industry
The challenges posed by expiring patents, the global economic slowdown, and price premium pressures are forcing the pharmaceutical and biotech industry to restructure and streamline…
Akorn to Acquire VersaPharm for $440 Million
Akorn, Inc. recently announced it has entered into a definitive agreement to acquire VPI Holdings Corp., the parent company of VersaPharm Incorporated, for $440 million…
Lundbeck to Acquire Chelsea Therapeutics in $658-Million Deal
H. Lundbeck A/S and Chelsea Therapeutics International, Ltd. recently announced the companies have entered into a definitive agreement under which Lundbeck will acquire Chelsea. Under…
Anokion Secures $37.5 Million, Big Names Invest
Anokion SA recently announced it has successfully closed a Series A financing round for $37.5 million. A group of leading life sciences venture capitalists, consisting…
Avantor Appoints New Chief Executive Officer
Avantor Performance Materials recently announced the appointment of Michael Stubblefield as its new Chief Executive Officer. Mr. Stubblefield assumes the role of CEO from Richard…
Horizon Discovery Licenses Gene Editing Technology From ERS Genomics
Horizon Discovery Group plc recently announced it has entered into a non-exclusive license agreement with ERS Genomics Ltd (ERS) to access intellectual property (IP) relating…
Arcadia Biosciences Raises $33 Million
Arcadia Biosciences, Inc. recently announced it has closed on a $33-million round of Series D preferred share equity financing. The round was led with an…
